Skip to main
XRAY
XRAY logo

DENTSPLY SIRONA (XRAY) Stock Forecast & Price Target

DENTSPLY SIRONA (XRAY) Analyst Ratings

Based on 24 analyst ratings
Hold
Strong Buy 17%
Buy 25%
Hold 54%
Sell 4%
Strong Sell 0%

Bulls say

Dentsply Sirona's recent performance indicates solid revenue growth, evidenced by a 2.8% increase in reported sales in Europe and 1.8% growth organically, suggesting the company's resilience and potential for sustained momentum. Additionally, revenues from Wellspect Healthcare reached $81 million, reflecting an impressive 8.6% reported increase and 6.7% organic growth, further reinforcing the overall positive financial trajectory. The combination of expected mid-single-digit revenue growth, potential market share gains in clear aligners, and improving margins supports a favorable outlook for Dentsply Sirona's stock.

Bears say

Dentsply Sirona's adjusted earnings per share (EPS) of $0.26 significantly underperformed the expected $0.43, largely due to lower-than-anticipated revenue, gross margin declines, and higher operating expenses. The revenue from the connected technology solutions segment declined by 8.3%, compounded by a $62 million loss linked to the Byte shutdown, contributing to a $0.24 negative impact on adjusted EPS. Additionally, with increased selling, general, and administrative expenses, coupled with a gross margin fall to 52.7%, the company's overall profitability and financial outlook appear increasingly challenging.

DENTSPLY SIRONA (XRAY) has been analyzed by 24 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 25% recommend Buy, 54% suggest Holding, 4% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DENTSPLY SIRONA and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DENTSPLY SIRONA (XRAY) Forecast

Analysts have given DENTSPLY SIRONA (XRAY) a Hold based on their latest research and market trends.

According to 24 analysts, DENTSPLY SIRONA (XRAY) has a Hold consensus rating as of Jul 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $38.21, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $38.21, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DENTSPLY SIRONA (XRAY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.